Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die provides insight into the natural history and pathophysiology of this complex syndrome, thereby allowing ...

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology (isolated STR), according to a study ...

Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online ...

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a major health concern. Pathological stimuli and interactions between cardiac fibroblasts (CFs) and other cell types may lead to ...

The EF is normally 50% to 75%, so heart failure with an EF of less than 50% is heart failure with reduced ejection fraction ...

For patients with heart failure with preserved ejection fraction, tirzepatide yields a reduced risk for a composite of death from cardiovascular causes or worsening heart failure.

What Are the Risk Factors for Death in Heart Failure With Preserved Ejection Fraction? Multiple variables are associated with survival in HFPEF. Key risk factors include age, gender, body mass ...

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology (isolated STR).

Lower risk for composite of death from cardiovascular causes or worsening heart failure seen with tirzepatide versus placebo. (HealthDay News) — For patients with heart failure with preserved ...

F RIDAY, Nov. 22, 2024 (HealthDay News) -- For patients with heart failure with preserved ejection fraction, tirzepatide yields a reduced risk for a composite of death from cardiovascular causes ...